Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, Mantle-Cell × prednylidene × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 11 Burkitt Lymphoma 11 Lymphoma, Large B-Cell, Diffuse 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Leukemia, Biphenotypic, Acute 3 Vasculitis, Central Nervous System 1 Urogenital Neoplasms 1 Stiff-Person Syndrome 1 Stage II Prostate Adenocarcinoma 1 Rasmussen subacute encephalitis 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1 Oropharyngeal Neoplasms 1 Opsoclonus-Myoclonus Syndrome 1 Neuromyelitis Optica 1 Myasthenia Gravis 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Mantle-Cell 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Lymphoma 1 Lung Neoplasms 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Lambert-Eaton Myasthenic Syndrome 1 HTLV-I Infections 1 Down Syndrome 1 Cranial Nerve Diseases 1

Interventions

Rituximab 19 Cyclophosphamide 15 fludarabine 9 acalabrutinib 9 venetoclax 8 ibrutinib 8 zanubrutinib 7 pirtobrutinib 7 Magnetic Resonance Spectroscopy 7 CT-P10 7 obinutuzumab 6 glofitamab 6 fludarabine phosphate 6 Cytarabine 6 Specimen Handling 5 Lenalidomide 5 Bendamustine Hydrochloride 5 Vincristine 4 Doxorubicin 4 Biopsy 4 Whole-Body Irradiation 3 Prednisone 3 Mycophenolic Acid 3 Immunotherapy, Adoptive 3 Etoposide 3 Dexamethasone 3 Cyclosporine 3 brexucabtagene autoleucel 2 Therapeutics 2 Tacrolimus 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02858804 2026-02-11

BDH-MCL01

Institute of Hematology & Blood Diseases Hospital, China

Phase 4 Completed

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡